- Datum04.12.2024
- Uhrzeit15:00 - 15:30 Uhr
- Veranstalter
stock3
Bastian Galuschka
Moderator
Amphastar Pharmaceuticals Inc. Registered Shares DL -,0001 Aktie
Verkaufen
Kaufen
Amphastar Pharmaceuticals Inc. Registered Shares DL -,0001 Chart
stock3 TerminalDu willst selbst ins Charting einsteigen?
Nutze das Charting-Widget auf dem stock3 Terminal für Deine eigene Analyse. Mehr Features. Mehr Werkzeuge. Mehr stock3.
Chart im Terminal öffnen
Amphastar Pharmaceuticals Inc. Registered Shares DL -,0001 Realtime-Kurs
| Name | Kurs | +/- (%) | +/- (abs) | Vortag | Zeit | Aktionen |
|---|---|---|---|---|---|---|
| L&S | VK | |||||
| Tradegate | VK | |||||
| Stuttgart | VK |
Passende Produkte
| WKN | Long/Short | KO | Hebel | Laufzeit | Bid | Ask |
|---|
Keine Ergebnisse gefunden
Wertentwicklung (Nasdaq)
1,15 %
Intraday
-1,03 %
1 Woche
-12,25 %
1 Monat
-27,90 %
Seit Jahresbeginn
-21,28 %
1 Jahr
117,43 %
3 Jahre
147,34 %
5 Jahre
322,30 %
10 Jahre
Wikifolio
Passender Service zu Amphastar Pharmaceuticals Inc. Registered Shares DL -,0001
Webinar zu Amphastar Pharmaceuticals Inc. Registered Shares DL -,0001
Kursinformationen (Nasdaq)
- Tagestief / Hoch ($)-
- 52W-Tief / Hoch ($)36,560-65,925
- Jahrestief / Hoch ($)36,560-65,925
- Schlusskurs (Vortag)
- Eröffnungskurs
- Volumen Intraday
Wichtigste Eigenschaften
Dividenden von Amphastar Pharmaceuticals Inc. Registered Shares DL -,0001
Keine Dividenden verfügbar
Termine von Amphastar Pharmaceuticals Inc. Registered Shares DL -,0001
Termine werden geladen...
Beschreibung
Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.
